Algernon Pharmaceuticals Inc.
|
|||
| Mailing Address: | 400 - 601 West Broadway Vancouver, BC V5Z 4C2 |
Head Office Address: | 400 - 601 West Broadway Vancouver, BC V5Z 4C2 |
| Contact Name: | James Kinley | Principal Regulator: | British Columbia |
| Business e-mail address: | info@algernonpharmacueuticals.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 604 398-4175 | Reporting Jurisdictions: | British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland |
| Fax Number: | Stock Exchange: | Canada - CSE | |
| Date of Formation: | Apr 10 2015 | Stock Symbol: | AGN |
| Jurisdiction Where Formed: | British Columbia | Auditor: | Smythe LLP |
| Industry Classification: | junior industrial | General Partner: | |
| CUSIP Number: | 01559R | Transfer Agent: | TSX Trust Company |
| Financial Year-End: | Aug 31 | Size of Issuer (Assets): | $5,000,001 to $25,000,000 |
|
